Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	418	352	189	320	198	314
Market Cap Growth	13.82%	86.79%	-41.07%	61.60%	-36.85%	25.86%
Enterprise Value	385	347	181	303	169	271
Last Close Price	16.00	16.40	8.78	14.90	9.22	14.60

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	-	-	-	85.08	-
Forward PE	-	38.92	13.41	3.90	108.00	108.00
PS Ratio	35.28	46.07	19.30	9.02	8.41	44.43
PB Ratio	4.22	3.76	2.17	3.43	2.10	3.40
P/TBV Ratio	17.04	3.76	2.17	3.43	2.10	3.40
P/FCF Ratio	-	-	-	424.69	-	-
P/OCF Ratio	-	-	-	361.41	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	32.50	45.31	18.55	8.54	7.19	38.35
EV/EBITDA Ratio	-	-	-	-	71.03	-
EV/EBIT Ratio	-	-	-	-	72.74	-
EV/FCF Ratio	-	-	-	402.14	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	-	0.04	0.02	-	-	-
Net Debt / Equity Ratio	-0.33	-0.18	-0.18	-0.18	-0.28	-0.45
Net Debt / EBITDA Ratio	2.69	1.14	1.16	8.09	-10.99	6.05
Net Debt / FCF Ratio	2.23	0.94	1.81	-22.56	3.97	8.37
Asset Turnover	0.12	0.08	0.10	0.35	0.23	0.09
Quick Ratio	6.12	4.74	2.59	3.28	4.82	4.71
Current Ratio	6.49	4.98	2.68	3.51	5.00	4.75
Return on Equity (ROE)	-13.72%	-16.29%	-25.74%	-1.93%	2.49%	-9.60%
Return on Assets (ROA)	-7.72%	-9.56%	-8.72%	-1.36%	1.43%	-5.40%
Return on Capital Employed (ROCE)	-11.50%	-15.80%	-15.60%	-2.40%	2.50%	-7.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-2.95%	-4.17%	-12.29%	-0.56%	1.18%	-2.21%
FCF Yield	-3.54%	-5.03%	-4.58%	0.24%	-3.33%	-1.59%
Buyback Yield / Dilution	-9.08%	-13.40%	-1.49%	2.19%	-7.50%	-22.58%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error